Hyperprogressive Disease (HPD) is Frequent in Non-Small Cell Lung Cancer (NSCLC) Patients (pts) Treated with Anti PD1/PD-L1 Monoclonal Antibodies (IO)
Annals of oncology(2017)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Annals of oncology(2017)